ENTITY
WuXi AppTec

WuXi AppTec (2359 HK)

623
Analysis
Health Care • China
WuXi AppTec is a global contract research, development, and manufacturing organization (CRDMO) for the pharmaceutical and life sciences industries. It provides integrated, end-to-end services including chemistry drug CRDMO, biology discovery, preclinical testing, and clinical research services for various therapeutic modalities. The company was founded in 2000 and is headquartered in Shanghai, China.
more
•09 Apr 2026 10:20

HK Short Interest Weekly: YOFC, Pop Mart Intl, China Hongqiao, AIA, Bidu, Zijin Gold International

We analyzed the latest HK SFC report for aggregate short position as of Mar 27 and highlight short interest changes in YOFC (6869 HK), Pop Mart...

Logo
178 Views
Share
•05 Apr 2026 10:15

A-H Premium Weekly (Apr 3rd): Great Wall Motor, China Coal Energy, China Minsheng Banking

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Great Wall Motor, China Coal Energy, China Minsheng Banking,...

Logo
211 Views
Share
•29 Mar 2026 10:15

A-H Premium Weekly (Mar 27th): Hans Cnc, Air China, CATL, Chongqing Rural Commercial Bank, Cgn Power

We analyzed A-H premium changes in the past week and highlight A-H premium changes for Hans Cnc, Air China, CATL, Chongqing Rural Commercial Bank,...

Logo
344 Views
Share
bearish•Hang Seng Index
•28 Mar 2026 07:00

Hong Kong Single Stock Options Weekly (Mar 23–27): Volatility Rises Amid Increased Hedging Activity

Rising volatility and weaker breadth set the tone for the week, with option flows and ETF activity pointing to a clear shift toward increased hedging.

Logo
John Ley
307 Views
Share
bullish•WuXi AppTec
•24 Mar 2026 08:30

WuXi AppTec (2359 HK): Core Business Drives 2025 Performance; Momentum to Continue

​WuXi AppTec reports record-high revenue and net profit in 2025, with backlog reaching RMB58B. The company guided for 2026 revenue of...

Logo
311 Views
Share
x